Hancom Lifecare is forecast to grow earnings and revenue by 82.3% and 14.3% per annum respectively. EPS is expected to grow by 82.4% per annum. Return on equity is forecast to be 4.9% in 3 years.
KOSE:A372910 - Analysts future estimates and past financials data (KRW Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2028
147,500
7,600
5,000
13,200
1
12/31/2027
142,200
6,200
4,100
12,100
1
12/31/2026
133,300
3,100
-2,500
5,000
1
3/31/2026
91,433
-7,164
12,443
17,800
N/A
12/31/2025
92,088
-7,725
16,751
22,676
N/A
9/30/2025
88,613
2,270
15,850
18,570
N/A
6/30/2025
88,593
-72
5,344
9,055
N/A
3/31/2025
97,783
5,018
14,527
19,229
N/A
12/31/2024
104,776
7,375
17,914
22,266
N/A
9/30/2024
121,555
6,444
1,926
6,057
N/A
6/30/2024
118,566
6,423
-21,947
-18,714
N/A
3/31/2024
117,798
2,333
-10,590
-6,422
N/A
12/31/2023
112,780
825
-13,823
-8,466
N/A
9/30/2023
107,465
7,821
-4,853
1,548
N/A
6/30/2023
106,940
8,510
24,791
32,248
N/A
3/31/2023
93,666
9,394
5,552
12,105
N/A
12/31/2022
100,120
9,204
-1,055
5,082
N/A
9/30/2022
99,895
162
13,440
18,949
N/A
6/30/2022
98,810
-1,715
1,847
5,499
N/A
3/31/2022
113,757
372
11,365
17,750
N/A
12/31/2021
121,140
4,835
18,462
28,051
N/A
9/30/2021
114,708
11,046
1,982
15,686
N/A
3/31/2021
154,073
26,923
-21,031
2,304
N/A
12/31/2020
151,842
27,690
-10,737
10,385
N/A
12/31/2019
66,586
-1,791
N/A
11,265
N/A
12/31/2018
99,008
20,434
N/A
22,246
N/A
12/31/2017
97,770
21,150
N/A
21,003
N/A
12/31/2016
106,995
22,209
N/A
31,711
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A372910 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.1%).
Earnings vs Market: A372910 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: A372910 is expected to become profitable in the next 3 years.
Revenue vs Market: A372910's revenue (14.3% per year) is forecast to grow slower than the KR market (16.4% per year).
High Growth Revenue: A372910's revenue (14.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A372910's Return on Equity is forecast to be low in 3 years time (4.9%).
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/16 18:31
End of Day Share Price
2026/07/16 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hancom Lifecare Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.